Literature DB >> 23517245

Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.

Han Wu1, Pei Chen, Rui Liao, Yi-Wei Li, Yong Yi, Jia-Xing Wang, Xiao-Yan Cai, Hong-Wei He, Jian-Jun Jin, Yun-Feng Cheng, Jia Fan, Jian Sun, Shuang-Jian Qiu.   

Abstract

BACKGROUND AND AIM: Regulatory T cells (Treg) play a vital role in immunosuppressive crosstalk; however, Tregs from different locations lead to different clinical outcomes. Our aim was, therefore, to compare the prevalences and suppressive phenotypes of Tregs in the peripheral blood, peritumor, and intratumor of patients with hepatocellular carcinoma (HCC). METHODS : The frequencies and phenotypes of CD4(+) CD25(+) CD127(low/-) CD49d(-) Tregs in the periphery, peritumor, and intratumor of 78 HCC patients and 12 healthy controls were evaluated by flow cytometry. Treg-cell suppressive activity was determined using an in vitro CD154 expression assay. Tregs from tumor and paired peritumor were then hybridized using an Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction. Functional analysis of the microarray data was performed using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analyses. RESULTS : Intratumoral Tregs exhibited higher frequencies and more suppressive phenotypic functions than those in peritumor and periphery, whereas there was no difference between the latter two. Functional analysis showed that complement cascades, p53, and glycosylphosphatidylinositol-anchor biosynthesis pathways were significantly upregulated in intratumoral Tregs; the salivary secretion pathway was significantly downregulated in intratumoral Tregs, and immune cells and tumor-immuno-related Gene Ontology terms were significantly affected. CONCLUSIONS : Tregs in different locations exhibited different functional statuses. A higher prevalence and more suppressive phenotype suggested a critical role for intratumoral Tregs in the formation of multicellular immunosuppressive networks. HCC immunotherapy may be improved, therefore, by specific locational Tregs elimination or suppression.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  gene microarray; hepatocellular carcinoma; immunosuppression; regulatory T cell; tumor immuno-escape

Mesh:

Substances:

Year:  2013        PMID: 23517245     DOI: 10.1111/jgh.12202

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Tumor-specific Th2 responses inhibit growth of CT26 colon-cancer cells in mice via converting intratumor regulatory T cells to Th9 cells.

Authors:  Jiang-Qi Liu; Xing-Yong Li; Hai-Qiong Yu; Gui Yang; Zhi-Qiang Liu; Xiao-Rui Geng; Shuai Wang; Li-Hua Mo; Lu Zeng; Miao Zhao; Yun-Ting Fu; Hong-Zhi Sun; Zhi-Gang Liu; Ping-Chang Yang
Journal:  Sci Rep       Date:  2015-06-02       Impact factor: 4.379

Review 2.  The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.

Authors:  Gaetano Bertino; Shirin Demma; Annalisa Ardiri; Maria Proiti; Alessandra Mangia; Salvatore Gruttadauria; Adriana Toro; Isidoro Di Carlo; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Michele Malaguarnera
Journal:  Biomed Res Int       Date:  2015-03-29       Impact factor: 3.411

3.  Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis.

Authors:  Lejia Sun; Gang Xu; Wenjun Liao; Huayu Yang; Haifeng Xu; Shunda Du; Haitao Zhao; Xin Lu; Xinting Sang; Yilei Mao
Journal:  Oncotarget       Date:  2017-06-13

4.  Comprehensive phenotyping of regulatory T cells after liver transplantation.

Authors:  Anna Gronert Álvarez; Paraskevi Fytili; Pothakamuri V Suneetha; Anke R M Kraft; Christin Brauner; Jerome Schlue; Till Krech; Frank Lehner; Christoph Meyer-Heithuis; Elmar Jaeckel; Juergen Klempnauer; Michael P Manns; Markus Cornberg; Heiner Wedemeyer
Journal:  Liver Transpl       Date:  2015-01-20       Impact factor: 5.799

5.  Regulatory T cell and activated natural killer cell infiltration in hepatocellular carcinoma: immune cell profiling using the CIBERSORT.

Authors:  Lixin Wang; Zongguo Yang; Yajuan Cao
Journal:  Ann Transl Med       Date:  2020-11

Review 6.  Adaptive immunity in the liver.

Authors:  Zongwen Shuai; Miranda Wy Leung; Xiaosong He; Weici Zhang; Guoxiang Yang; Patrick Sc Leung; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2016-03-21       Impact factor: 11.530

Review 7.  Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.

Authors:  Wei Li; Jun Han; Hong Wu
Journal:  Chronic Dis Transl Med       Date:  2016-11-09

Review 8.  New emerging targets in cancer immunotherapy: the role of GITR.

Authors:  Giulia Buzzatti; Chiara Dellepiane; Lucia Del Mastro
Journal:  ESMO Open       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.